According to TechSci Research’s report, titled “Ankylosing Spondylitis Therapeutics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028,” the Global Ankylosing Spondylitis Therapeutics Market reached a valuation of USD 4.41 billion in 2022. The market is poised for continued growth, projected at a CAGR of 7.51% during the forecast period from 2024 to 2028.
Understanding Ankylosing Spondylitis
Chronic Inflammatory Condition:
Ankylosing spondylitis (AS) is a chronic inflammatory condition primarily affecting the spine, resulting in pain, stiffness, and reduced mobility. This autoimmune disease impacts millions of individuals worldwide, driving the continuous evolution of the global ankylosing spondylitis market to meet the demand for effective treatments and management solutions.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Global Ankylosing Spondylitis Therapeutics Market.” – https://www.techsciresearch.com/report/ankylosing-spondylitis-therapeutics-market/16738.html
Factors Fueling the Global AS Market
One of the primary drivers of the global AS market is the rising prevalence of ankylosing spondylitis. AS is becoming increasingly common, with over 2 million individuals estimated to have the condition in the United States alone. Similar trends are observed worldwide, leading to a growing demand for improved treatment options.
Advancements in Research:
Significant advancements have occurred in understanding AS at molecular and genetic levels. Researchers have made substantial progress in unraveling the disease’s complex pathophysiology, identifying key biomarkers, and exploring potential therapeutic targets. These breakthroughs are driving the development of innovative drugs and treatment approaches, offering more effective ways to manage the condition.
Biologic drugs, including TNF-alpha inhibitors (e.g., Adalimumab, Infliximab) and IL-17 inhibitors (e.g., Secukinumab), have transformed AS treatment. These biologics have proven highly effective in controlling inflammation and improving patients’ quality of life. Ongoing research and development efforts have led to the introduction of new biologics with enhanced efficacy and safety profiles, contributing significantly to market growth.
AS typically manifests in young adults but is often a lifelong condition. As the global population ages, a substantial number of individuals are living longer with AS. This demographic shift results in a larger patient pool seeking continuous medical care and treatment, further stimulating market expansion.
The growing awareness of ankylosing spondylitis, driven by patient advocacy groups and awareness campaigns, is another driving force behind the global AS market. These initiatives reduce diagnostic delays associated with AS, leading to earlier intervention and improved disease management. As more individuals are diagnosed and seek treatment, the market for AS-related medications, devices, and services continues to expand.
Segmentation and Regional Insights
End Use Segment:
- Hospitals: The predominant market leader due to the multi-disciplinary approach required for AS management, including rheumatologists, physical therapists, and comprehensive care infrastructure.
- North America: Expected to grow during the forecast period, particularly in the United States, known for its high healthcare spending, investment in new AS treatments, and a sizable AS patient population.
- Asia Pacific: Experiencing rapid market growth with active patient advocacy and support groups raising awareness, supporting research, and influencing treatment options and market dynamics.
Major companies operating in Global Ankylosing Spondylitis Therapeutics Market are:
- AbbVie, Inc.
- Amgen, Inc.
- Pfizer, Inc.
- Novartis AG
- Eli Lilly and Company
- UCB, Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
Customers can also request 10% free customization in this report.
“The global ankylosing spondylitis market is poised for significant growth, driven by factors such as increasing prevalence, advances in medical research, the biologics revolution, an aging population, patient advocacy and awareness, and favorable reimbursement policies. These drivers are creating opportunities for pharmaceutical companies, healthcare providers, and other stakeholders to develop and deliver innovative treatments and solutions for AS patients. As research continues and new therapies emerge, the outlook for the global AS market remains promising in its efforts to improve the lives of those affected by this chronic autoimmune condition.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.
“Ankylosing Spondylitis Therapeutics Market By By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia), By End Use (Hospitals, Clinics, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Ankylosing Spondylitis Therapeutics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Ankylosing Spondylitis Therapeutics Market.
What Will You Get in the Sample Report?
The sample report will provide comprehensive insights into the Global Ankylosing Spondylitis Therapeutics Market, including market size, growth projections, key drivers, challenges, and emerging trends. It will also offer valuable information about the competitive landscape and the strategies adopted by major players in the industry.
Who Will Benefit from This Report?
This report will be valuable for pharmaceutical companies, healthcare providers, researchers, patient advocacy groups, and investors. It serves as a crucial resource for decision-making, strategic planning, and market analysis in the dynamic and evolving Global Ankylosing Spondylitis Therapeutics Market.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=16738
Recently Published Reports –
Contact Techsci Research-
Mr. Ken Mathews
708 Third Avenue,
New York – 10017
S-01, 2.floor, Subbelrather Straße,
Tel: +49 221 65058833
Email: [email protected]